Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorBeijing Tiantan Hospital

About this trial

Moyamoya disease is characterized by progressive stenosis of the genesis of the distal internal carotid arteries bilaterally and progressive generation of compensatory pathological vascular networks at the basis cranii, and these pathological vasculature has poor vascular reactivity. Perioperative circulatory management of patients with smoky vessels to ensure perfusion of brain tissue and integrity of brain network during surgery to minimize postoperative impairment of neurological functions, including motor, sensory, emotional and cognitive functions, is the key point of perioperative circulatory management of moyamoya disease. Functional Magnetic Resonance Imaging (fMRI) has been routinely used in various cerebrovascular diseases to further evaluate cerebrovascular reserve and cerebral network connectivity. The purpose of this study is to observe the changes in cerebral blood flow, cerebral oxygen metabolism, cerebral oxygen metabolism rate, and cerebral network connectivity in adult patients with moyamoya disease in cerebral ischemia-sensitive areas under anesthesia to provide a basis for exploring anesthesia management to improve cognitive function and cerebral network connectivity in these patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with moyamoya disease scheduled for direct or indirect intracranial and extracranial revascularization surgery

Age between 18-65 years

Obtain written informed consent.

Disqualifiers

Patients with preoperative claustrophobia, sensory or motor aphasia that are unable to understand and cooperate with the examination

Preoperative cranial imaging suggesting cerebral infarction lesion diameter >15mm

Patients allergic to anesthetic drugs

Metal implants in the body

Trial population

We plan to recruit consecutive patients with moyamoya disease who are to undergo direct or indirect revascularization surgery from August 2023 to December 2025 at Beijing Tiantan Hospital of Capital Medical University.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Changes of brain functional network

Time frame
Before sedation, after sedation and after maintenan the blood pressure at baseline 100%-120% for 15min

Secondary outcomes

1

Postoperative delirium

Time frame
Day1-5 after surgery
2

Electroencephalogram changes

Time frame
Before sedation, after sedation and after maintenan the blood pressure at baseline 100%-120% for 15min

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.